U.S. flag

An official website of the United States government

NM_002495.4(NDUFS4):c.355G>C (p.Asp119His) AND Mitochondrial complex I deficiency, nuclear type 1

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Oct 30, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002532977.2

Allele description [Variation Report for NM_002495.4(NDUFS4):c.355G>C (p.Asp119His)]

NM_002495.4(NDUFS4):c.355G>C (p.Asp119His)

Gene:
NDUFS4:NADH:ubiquinone oxidoreductase subunit S4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q11.2
Genomic location:
Preferred name:
NM_002495.4(NDUFS4):c.355G>C (p.Asp119His)
HGVS:
  • NC_000005.10:g.53658555G>C
  • NG_008200.1:g.102921G>C
  • NM_001318051.2:c.350+12150G>C
  • NM_002495.4:c.355G>CMANE SELECT
  • NP_002486.1:p.Asp119His
  • NC_000005.9:g.52954385G>C
  • NM_002495.3:c.355G>C
  • NR_134473.2:n.551G>C
  • NR_134474.2:n.468G>C
  • NR_134475.2:n.503G>C
Protein change:
D119H
Links:
dbSNP: rs747359752
NCBI 1000 Genomes Browser:
rs747359752
Molecular consequence:
  • NM_001318051.2:c.350+12150G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_002495.4:c.355G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134473.2:n.551G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_134474.2:n.468G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_134475.2:n.503G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Mitochondrial complex I deficiency, nuclear type 1
Synonyms:
NADH-COENZYME Q REDUCTASE DEFICIENCY; MITOCHONDRIAL NADH DEHYDROGENASE COMPONENT OF COMPLEX I, DEFICIENCY OF
Identifiers:
MONDO: MONDO:0100224; MedGen: CN257533; OMIM: 252010

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002820968Genomics, Clalit Research Institute, Clalit Health Care
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV004197754Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 30, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement.

Leshinsky-Silver E, Lebre AS, Minai L, Saada A, Steffann J, Cohen S, Rötig A, Munnich A, Lev D, Lerman-Sagie T.

Mol Genet Metab. 2009 Jul;97(3):185-9. doi: 10.1016/j.ymgme.2009.03.002. Epub 2009 Mar 11.

PubMed [citation]
PMID:
19364667

Exploring mTOR inhibition as treatment for mitochondrial disease.

Sage-Schwaede A, Engelstad K, Salazar R, Curcio A, Khandji A, Garvin JH Jr, De Vivo DC.

Ann Clin Transl Neurol. 2019 Sep;6(9):1877-1881. doi: 10.1002/acn3.50846. Epub 2019 Aug 6.

PubMed [citation]
PMID:
31386302
PMCID:
PMC6764630
See all PubMed Citations (4)

Details of each submission

From Genomics, Clalit Research Institute, Clalit Health Care, SCV002820968.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
11not providednot providedclinical testing PubMed (4)

Description

INHERITANCE: The variant was identified in the homozygous state in a patient affected by Leigh syndrome. FREQUENCY: The variant is very rare, observed in 2 / 251,172 (0.0008%) of alleles in the gnomAD v2.1.1 reference population dataset. VARIANT TYPE: Missense variant in a gene for which missense variation is a documented mechanism of disease. IN SILICO PREDICTIONS: Multiple lines of computational evidence unanimously predict a deleterious effect on the gene or gene product. The substitution replaces a highly conserved, negatively charged residue, Aspartate, with a positively charged residue, Histidine. SOURCES: This variant has been reported in ClinVar with the following classifications: VUS (2). It has also been previously described in several publications (see PMID: 19364667, 31386302, and 31292494). Notably, these studies separately describe two additional patients with the clinical diagnosis of Leigh syndrome who were carriers of this variant either in the heterozygous state, in trans with a second pathogenic variant (PMID: 19364667), or in the homozygous state (PMID: 31386302). Taken together, we interpret this variant as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Baylor Genetics, SCV004197754.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024